Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|April 23, 2014
Experience of barriers and motivations for physical activities and exercise during treatment of pediatric patients with cancerMiriam Götte, Sabine Kesting, Corinna Winter, et al.
Scientific Reports|October 30, 2020
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoringChristian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, et al.
Anti-Cancer Drugs|August 19, 2006
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell linesClaudia Lanvers-Kaminsky, Alexis Bremer, Uta Dirksen, et al.
Onkologie|February 1, 2007
Implementing Good Clinical Practice in two noncommercial phase II studies in children with cancerAlexandra Wagner-Bohn, Anita Ripkens-Reinhard, Gerlinde Benninger-Döring, et al.
Pediatric Hematology and Oncology|March 2, 2012
Population pharmacokinetics of native Escherichia coli asparaginaseStephan Borghorst, Rob Pieters, Hans-Juergen Kuehnel, et al.
European Journal of Pediatrics|November 28, 2014
Motor performance in children and adolescents with cancer at the end of acute treatment phaseMiriam Götte, Sabine V Kesting, Corinna C Winter, et al.
Journal of Pediatric Hematology/Oncology|July 25, 2015
Motor Performance After Treatment for Pediatric Bone TumorsSabine V Kesting, Miriam Götte, Corinna C Seidel, et al.
Pediatric Blood & Cancer|December 19, 2015
One in Four Questioned Children Faces Problems Regarding Reintegration Into Physical Education at School After Treatment for Pediatric CancerSabine V Kesting, Miriam Götte, Corinna C Seidel, et al.
Pageof 10